Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Despite new, more equitable approaches for allocating donor livers to patients, women are at a disadvantage and are more likely to die waiting for a transplant than men. A recent study in JAMA Surgery identified a strategy to address this disparity.
The study was led by Dr. Mamatha Bhat of UHN's Ajmera Transplant Centre and the Toronto General Research Hospital Institute (TGHRI) Transplant Hepatology, and first author and fellow Dr. Ravikiran Karnam.
"We explored whether access to living donation could improve women's chances of receiving a donor organ," says Dr. Bhat.
Liver transplantation is the only treatment available for patients with end-stage liver disease. Because the demand for donor livers is greater than the supply, medical professionals select the patients who are most in need. To do this, a test, known as the Model for End-stage Liver Diseases (MELD), is used.
Although MELD has helped to improve how donor organs are allocated to those in need, inequalities remain. Because of a number of factors like a person's height, the amount of muscle mass or the size of the liver, women's MELD values are lower than men's for the same severity of liver disease. A previous study suggests that this reduces women's chances of receiving a liver by half.
To address this issue, Dr. Bhat led a clinical study to see whether access to living donation could improve women's chances of receiving a transplant. The study included 1,289 adult patients on the waiting list for a liver transplant at UHN in Toronto and living donations were received from the Living Donor Liver Program led by Drs. Mark Cattral and Dr. Nazia Selzner.
When patients had access to deceased donors, the chances of receiving a transplant were higher in men than in woman. However, when patients had access to a living donor, the chances of receiving an organ were equal between men and women.
"Our findings suggest that expanding access to living donor liver transplantation across transplant programs could help overcome the multifaceted problems of access to organs from deceased donors," clarifies Dr. Bhat.
"While access to living donation benefits both men and women, this approach has the potential to particularly help women, who are at a disadvantage for deceased donor organs on the waiting list," comments Dr. Bhat. "What we show here is that, by performing living donor liver transplants, our program is able to alleviate sex disparity on the waiting list.
"Our work also highlights the need to refine current clinical tests such as MELD to ensure that the process of organ allocation is truly unbiased."
Dr. Bhat's research has been supported by the Canadian Liver Foundation, American Society of Transplantation, Canadian Donation and Transplant Research Program, and UHN Foundation.
Read more about the study